ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope

New NeuraLight 3D Ultra Module Expands Neuroscience Research Capabilities

Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima multiphoton microscopes. NeuraLight 3D Ultra provides revolutionary 3D holographic photostimulation, specifically optimized for functional and large-scale studies of neural networks and brain computation. Building upon Bruker’s proprietary spatial light modulator (SLM) technology, the NeuraLight 3D Ultra module utilizes a new, larger liquid crystal chip that unlocks access to a larger field of view, improved targeting precision, and a market-leading speed of 600 hologram frames per second. Paired with the imaging capabilities of the Ultima 2Pplus microscope, it uniquely allows researchers to study mechanisms of behavior, perception, and disease at a larger scale and on a time scale that is reflective of the underlying biology.

“The system is performing very well in our laboratory, and we’re excited about the NeuraLight 3D Ultra’s speed, field of view, and resolution, which will enable us to perform all-optical interrogation experiments with greater fidelity and precision,” said Dr. Adam Packer, Wellcome Trust Sir Henry Dale Fellow at the University of Oxford. “The new format SLM and associated optical relays offer a better tradeoff between field of view and resolution that will be advantageous to addressing larger numbers of cells with improved accuracy. Additionally, the very fast update speed of the system will make it possible to activate sequences of cells at a high rate.”

“We are pleased to continue to develop innovative instrumentation in close collaboration with leaders in neuroscience research,” added Xiaomei Li, Ph.D., Vice President and General Manager for Bruker’s Fluorescence Microscopy Business. “With its largest in-class field of view in fast resonant mode, the Ultima 2Pplus microscope equipped with NeuraLight 3D Ultra is an optimized solution for all-optical interrogations of the brain.”

About NeuraLight 3D Ultra

The NeuraLight 3D Ultra is a module that strengthens and diversifies the functionality of Bruker’s Ultima multiphoton microscopes. These pioneering imaging systems have a proven track record of facilitating complex research in neuroscience and were first to enable simultaneous imaging and photostimulation of biological samples. NeuraLight 3D Ultra easily couples to one of the optical ports of the Ultima microscope to allow for independent imaging and simultaneous multicellular photostimulation. Comprehensive software enables user-friendly selection of targets in three dimensions with well-defined timing. The NeuraLight 3D Ultra module is available as an option for all new Ultima 2Pplus multiphoton microscopes and as an upgrade for selected models of microscopes produced since 2006. Ultima multiphoton systems equipped with NeuraLight 3D Ultra and paired with Bruker’s electrotunable lens option provide complete solutions for all-optical reading and writing of neuronal activity.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.